Crossmark

Therapeutic potential of AAV2-shmTOR gene therapy in reducing retinal inflammation and preserving endothelial Integrity in age-related macular degeneration

Crossref DOI link: https://doi.org/10.1038/s41598-025-93993-4

Published Online: 2025-03-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Jin

Moon, Seo Yun

Kang, Ho Geun

Kim, Hee Jong

Choi, Jun Sub

Lee, Steven Hyun Seung

Park, Keerang

Won, So-Yoon
License Information

Text and Data Mining valid from 2025-03-19

Version of Record valid from 2025-03-19
More Information

Article History

Received: 25 September 2024

Accepted: 11 March 2025

First Online: 19 March 2025

Declarations

:

: The authors declare no competing interests.

: No consent to participate was required for this study.

: All authors consented to publication.

Document is current

Any future updates will be listed below